Prescription Review Program

No content found

No content found

No content found

Physicians with Prescribing Restrictions  •   Prescribing Requirements for Residents


Physicians with Prescribing Restrictions


The physicians listed below are subject to prescribing restrictions relating to PRP or other medications, as indicated.

Physician Effective Date
Description
     
Dr. Yakub Abu-Ghazaleh  July 26, 2019

Dr. Abu-Ghazaleh has entered into an undertaking which includes the following:

  1. He will work with his chronic pain patients to assist them to transition their care to another physician, and will discontinue prescribing prescription review medications to chronic pain patients within 12 months;
  2. He will review his prescribing to all chronic pain patients to assess whether the prescribing is appropriate, and if he concludes that it is not appropriate, he will alter his prescribing to what is appropriate;
  3. If after reviewing his prescribing to chronic pain patients he decides to continue prescribing opioid doses in excess of 90 morphine equivalents per day, he will obtain a signed acknowledgement that the patient is aware of the risks of such prescribing and the patient is either given a prescription for Naloxone or instructions on how to obtain a Naloxone kit.

Undertaking

Dr. Murray Davies  December 1, 2016 Dr. Davies has signed an undertaking with the College in which he has agreed that he will not prescribe, order, dispense or administer any Prescription Review medication or Pregabalin (Lyrica), Tramadol, Zopiclone, Baclofen or Cyclobenzaprine

Dr. Davies is able to prescribe opiates in two circumstances:

1. To inpatients who require opiates for acute pain management only of his or her condition.
2. To emergency room patients when he is on call who require opiates for acute pain management only.


Dr. Russel Knaus  2010

Dr. Knaus is subject to a penalty order which prohibits him from prescribing thyroid replacement therapy or Lugol’s iodine.

Dr. Narinda Maree  June 21, 2019 Council has prohibited Dr. Maree from prescribing any medication that is listed in the Prescription Review Program of the College.
Dr. Oluwatomi Mitchell September 4, 2017

Dr. Mitchell has signed an undertaking with the College that she will not prescribe any opioids to any patient.

Dr. Andre Van Der Merwe  August 29, 2017

Dr. Andre Van der Merwe has signed an undertaking with the College that he will not prescribe any Prescription Review medications to any patient.

Dr. Jordan Velestuk November 21, 2016

Dr. Velestuk has signed an undertaking with the College that he will not order, dispense, prescribe or administer any Prescription Review medications or order, dispense, prescribe or administer ketamine to any patient.

     
     


Prescribing Requirements for Residents

As a result of a recent disciplinary investigation, the College became aware that some residents and some supervising physicians are unaware of the College’s requirements for residents to prescribe medications. These requirements apply to medications dispensed by pharmacists to patients in the community, not to medications that are dispensed pursuant to a hospital order. 

Requirements related to all prescriptions

Regulatory Bylaw 17.1 sets out the requirements that apply to all written and verbal prescriptions issued by physicians. There is an additional requirement that residents place the name of the supervising physician on the script:

(i) Physicians in training who are enrolled on the educational register of the College of Physicians and Surgeons and who may be authorized to issue prescriptions must clearly identify on the prescription the name of the fully registered physician who is their supervisor in respect to that specific physician/patient interaction.

The College requires this so that pharmacists who receive these prescriptions will be able to contact the supervising physician with any questions or concerns related to the prescription. 

 

Requirements related to Prescription Review medications

Regulatory Bylaw 18.1 sets out the additional requirements that apply to prescriptions for prescription review medications. PRP medications include opioids, benzodiazepines, gabapentin, stimulants, etc. The bylaw contains a complete list of the medications that are subject to the bylaw. 

In addition to the general requirements for writing such prescriptions, the bylaw imposes additional requirements if the writer is a resident:

(f) If a physician is registered on the Educational Register, the physician shall, in addition to the information in paragraph (c) [of the bylaw] above, include the following in a prescription for a drug to which the Prescription Review Program applies:

(i) The training level of the physician writing the prescription;

(ii) The legibly printed name of the Most Responsible Physician (the physician to whom queries regarding the prescription should be addressed); 

(iii) The legibly printed name of the physician writing the prescription.

Residents and physicians who supervise residents should be aware of these requirements to avoid patients having problems obtaining prescribed medications as a result of incomplete prescriptions. 


 


No content found